Food and Drug Administration (FDA)

India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

Topics • Technology

GDUFA’s Impact on the API Industry – an Update

GSK Combined Melanoma Treatment Delayed in Europe

Lilly-Boehringer Diabetes Drug Halted by FDA

Generic Drugmakers Ramp up Campaign Against FDA Label Plan

Drug Maker Boehringer Facing U.S. Lawsuits

Daiichi Sankyo Pledges “Bold Action” on Ranbaxy Ban

Sanofi Challenges Lilly’s Challenge of Lantus Patents

J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

Sanofi’s Lemtrada Suffers Setback In Key U.S. Market

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

FDA Warns Of Heart Risks with Astellas Stress Test Chemicals

J&J reaches $4 Billion Deal On Hip Implant Lawsuits

Roche Wins FDA Approval for Breakthrough Leukemia Drug

Topics • Technology

Sourcing from India and China

Ending Drug Trial Secrecy Is a Boon for R&D, Says EU Agency

Roche Breast Cancer Drug Gets U.S. Pre-Surgery Approval

Topics • Technology

United in Philosophy and Approach

Topics • Technology

Enzymes as a Catalytic All Rounder

Topics • Technology

GDUFA’s Impact on the API Industry

Topics • Chemistry

Buyer Beware, Patient Beware

Probe Indicates Biotech Wheat Was "Isolated Incident"

FDA Panel Votes to Relax Avandia Restrictions

U.S. Finds Unapproved Genetically Modified Wheat in Oregon

Elan Strikes $1 Billion Royalty Deal with Theravance

Judge Denies FDA Bid to Stay 'Morning-after' Pill Ruling

U.S. Lawmakers Advance Bill on Prescription Drug Tracking

FDA to Consider Revamping Food Additive Rules

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

U.S. Launch of Novo's New Insulin Faces Long Delay

U.S. GMO Food Labeling Drive Has Biotech Industry Biting Back

Genetically Engineered Salmon Company Expects US Regulatory OK in 2013

New Technology Speeding Progress on Bird Flu Vaccine

Topics • Technology

Insight into the Cosmeceutical Market

Some U.S. Farm Groups Vow to Protect Pro-Monsanto 'Rider'

85 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Predictive Simulation in Pharma Production

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.